Myriad Genetic Laboratories offers gene sequencing, the most analytically sensitive and accurate method of genetic testing.

BRACAnalysis^® — For patients at risk for hereditary breast and ovarian cancer.

	Comprehensive BRACAnalysis®: BRCA1 and BRCA2 gene sequence analysis and a panel of large rearrangements for susceptibility to breast and ovarian cancer.
	Single Site BRACAnalysis®: Single-mutation analysis for susceptibility to breast and ovarian cancer for individuals with known BRCA1 or BRCA2 mutations in their family.
	Multisite 3 BRACAnalysis®: Three-mutation BRCA1 and BRCA2 analysis for genetic susceptibility to breast and ovarian cancer for Ashkenazi individuals.

COLARIS^® — For patients at risk for hereditary nonpolyposis colorectal cancer (HNPCC).

	Comprehensive COLARIS®: MLH1 and MSH2 gene sequence and large rearrangement analysis for diagnosis of hereditary nonpolyposis colorectal cancer syndrome (HNPCC).
	Single Site COLARIS®: Single-mutation analysis for diagnosis of HNPCC for individuals with a known MLH1 or MSH2 mutation in the family.

COLARIS AP ^® — For patients at risk for adenomatous polyposis syndromes.

	Comprehensive COLARIS AP ®: APC gene sequence and large rearrangement analysis for diagnosis of familial adenomatous polyposis (FAP) or attenuated FAP (AFAP) and an MYH mutation panel for diagnosis of MYH-associated polyposis (MAP).
	Single Site COLARIS AP ®: Single mutation analysis for diagnosis of adenomatous polyposis syndromes for individuals with known APC or MYH mutations in the family.

MELARIS^® — For patients at risk for hereditary melanoma.

	Comprehensive MELARIS®: p16 gene sequence analysis for diagnosis of hereditary melanoma.
	Single Site MELARIS®: Single mutation analysis for diagnosis of hereditary melanoma for individuals with a known p16 mutation in the family.

» More